SUMMARY In this study it is shown that drug prescription is subject to cyclical variation throughout the year, but that the patterns of variation for different types of drug are different. Some 
There now exists considerable evidence for a cyclical variation in the occurrence of a variety of psychiatric disorders, including depression,' mania,2 schizophrenia,3 and suicide.4 Cyclical variation in neurosis is, however, more equivocal: McCartney5 found a seasonal variation in neurosis referrals to American private practice, and Kellner" found that general practitioner (GP) attendances for neurosis were 'somewhat larger in the winter months '. However, Hare and Walter3 found that, compared with schizophrenia and mania, there was little seasonal variation in admissions to hospital for neurosis and other non-psychotic psychiatric conditions.
There is also evidence that at least one form of psychiatric treatment is subject to cyclical variation in its use. Eastwood and Peacockel found the use of electric convulsion therapy (ECT) in Ontario to be subject to regular variation throughout the year, with peak use corresponding with the annual peaks in suicide and admissions to hospital with depression. In this paper we report on cyclical variation in the prescription of psychotropic drugs by GPs. Apart from any intrinsic interest, such a study is relevant to three issues:
(1) The relationship between prescribing patterns of the different types of drug.
(2) The relationship between patterns of prescribing and patterns of pathology. The yearly cycle in non-psychotropic prescriptions corresponds closely to that for general practice consultations for physical illness,6 with the winter excess accounted for by the increased incidence of respiratory disease.
It is known that admissions to hospital for depression and suicide are subject to cyclical variations, with peaks in spring and autumn.' In the same study, the authors observed that the spring peak for admissions for psychotic depression was greater than the autumn peak, whereas the reverse was true for neurotic depression.
Our findings, however, are of a thrice-yearly rather than twice-yearly cycle for antidepressants and tranquillisers; the 'additional' peak, smaller for tranquillisers than for antidepressants, occurs in late winter. This four-monthly cycle is similar to that found by Hare and Walter for neurosis admissions, although the phases are different: peak prescribing occurs in February, April-May, and September-October, whereas the peaks in admissions occurred in February-March, June-July, and October-November. Thus, in two cases out of three, the prescription peak precedes the admissions peak. This may represent the natural history of increased prevalence of the disorder, admission occurring only after psychotropic drug therapy in general practice has been unsuccessful.
There is an alternative explanation for the 'extra' peak, in 
